Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

August 31, 2017

Conditions
Tinnitus, Subjective
Interventions
DRUG

Sulodexide

25 mg morning and evening for 40 days

DRUG

Placebo

1 tablet morning and evening for 40 days

Trial Locations (1)

Unknown

St Jospeh University, Beirut

All Listed Sponsors
lead

St Joseph University, Beirut, Lebanon

OTHER

NCT02737670 - Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus | Biotech Hunter | Biotech Hunter